The pharmaceutical industry makes substantial investments in GMP-compliant production areas, automation and digital systems. However, as technological standardisation increases, the differentiation between sites is shifting. Against this backdrop, the question arises as to which factors contribute to resilience against external influences such as skills shortages, regulatory pressure and market changes. Alongside technical equipment, leadership models…